Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2002-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.302.3.1158PMID 12183676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia.

  2001cited by this paper
• Anesthetics and ion channels: molecular models and sites of action.

  2001cited by this paper
• The Effect of Altered Cerebral Blood Flow on the Cerebral Kinetics of Thiopental and Propofol in Sheep

  2000cited by this paper
• High-performance liquid chromatography of the neuroactive steroids alphaxalone and pregnanolone in plasma using dansyl hydrazine as fluorescent label: application to a pharmacokinetic-pharmacodynamic study in rats.

  2000cited by this paper
• Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: prediction of tissue-dependent efficacy in vivo.

  1999cited by this paper
• Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam.

  1999influential reference
• Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders.

  1999cited by this paper
• Characterization of the Pharmacodynamic Interaction between Parent Drug and Active Metabolite In Vivo: Midazolam and α-OH-Midazolam

  1999cited by this paper
• Acetazolamide and amiloride inhibit pentobarbital-induced facilitation of nocifensive reflexes.

  1999cited by this paper
• Biphasic Modulation of GABAA Receptor Binding by Steroids Suggests Functional Correlates

  1999cited by this paper
• Application of a Combined “Effect Compartment/Indirect Response Model” to the Central Nervous System Effects of Tiagabine in the Rat

  1999cited by this paper
• Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs

  1999cited by this paper
• Mechanism-Based Modeling of Adaptive Changes in the Pharmacodynamics of Midazolam in the Kindling Model of Epilepsy

  1999cited by this paper
• On the mechanism of GABA-induced currents in cultured rat cortical neurons

  1999cited by this paper
• Neuroactive steroids induce GABAA receptor‐mediated depolarizing postsynaptic potentials in hippocampal CA1 pyramidal cells of the rat

  1998cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.

  1998cited by this paper
• Influence of Different Fat Emulsion-Based Intravenous Formulations on the Pharmacokinetics and Pharmacodynamics of Propofol

  1998cited by this paper
• Anesthetic activity of novel water-soluble 2 beta-morpholinyl steroids and their modulatory effects at GABAA receptors.

  1997cited by this paper
• Parameter estimability of biphasic response models.

  1997cited by this paper
• Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.

  1997cited by this paper
• The anaesthetic action and modulation of GABAA receptor activity by the novel water-soluble aminosteroid Org 20599.

  1996cited by this paper
• Steroid anesthetics: old compounds, new drugs.

  1996influential reference
• Preparation, Characterization, and Anesthetic Properties of 2-Hydroxypropyl-β-cyclodextrin Complexes of Pregnanolone and Pregnenolone in Rat and Mouse

  1995cited by this paper
• Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse.

  1995cited by this paper
• Neurosteroids and GABAA receptor function.

  1995influential reference
• Neuroactive steroids

  1992cited by this paper
• Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs.

  1992cited by this paper
• Pharmacodynamic characterization of the electroencephalographic effects of thiopental in rats

  1991cited by this paper
• Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions

  1991cited by this paper
• Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis

  1990cited by this paper
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm

  1987cited by this paper
• Anesthetics produce differential actions on the discharge activity of a single neuron.

  1987cited by this paper
• Modulation of GABAA receptor activity by alphaxalone

  1987cited by this paper
• Operational models of pharmacological agonism

  1983cited by this paper
• Metabolism of alphaxalone in the rat: evidence for the limitation of the anaesthetic effect by the rate of degradation through the hepatic mixed function oxygenase system.

  1981influential reference
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

  1980cited by this paper
• Alphaxalone distribution in rat tissues.

  1979cited by this paper
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine

  1979cited by this paper
• Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: Studies on clonidine in the rat and cat

  1979cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• The protein binding of alphaxalone.

  1972cited by this paper
• Metabolism and excretion of Althesin (CT 1341) in the rat.

  1972cited by this paper
• The protein binding of alphaxalone.

  1972cited by this paper
• CORRELATIONS BETWEEN THE CHEMICAL STRUCTURE AND THE PHARMACOLOGICAL ACTIONS OF THE STEROIDS1

  1942cited by this paper

• The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis

  2024cites this paper
• The use of alfaxalone for short-term anesthesia can confound serum progesterone measurements in the common marmoset: a case report

  2022cites this paper
• Sex-specific hypnotic effects of the neuroactive steroid (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile are mediated by peripheral metabolism into an active hypnotic steroid.

  2022cites this paper
• Alfaxalone population pharmacokinetics in the rat: Model application for pharmacokinetic and pharmacodynamic design in inbred and outbred strains and sexes

  2022cites this paper
• Non-sedative cortical EEG signatures of allopregnanolone and functional comparators

  2022cites this paper
• Differential effects of the novel neurosteroid hypnotic (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile on electroencephalogram activity in male and female rats

  2021cites this paper
• Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol.

  2021cites this paper
• Introduction: Utility of Mathematical Models in Drug Development and Delivery

  2021cites this paper
• Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone Administered as a Bolus Intravenous Injection of Phaxan in a Phase 1 Randomized Trial

  2020cites this paper
• Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator

  2020cites this paper
• A Comparative Study of Intramuscular Alfaxalone- or Ketamine-Based Anesthetic Mixtures in Gray Squirrels Undergoing Gonadectomy: Clinical and Physiologic Findings

  2020cites this paper
• Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modelling

  2020cites this paper
• Intramuscular Administration of Alfaxalone Alone and in Combination for Sedation and Anesthesia of Rabbits (Oryctolagus cuniculus).

  2019cites this paper
• Pharmacokinetics and sedative effects of alfaxalone with or without dexmedetomidine in rabbits.

  2019cites this paper
• A question of time.

  2018cites this paper
• Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics

  2018cites this paper
• Past, Present, and Future of Bioequivalence: Improving Assessment and Extrapolation of Therapeutic Equivalence for Oral Drug Products.

  2018cites this paper
• Pharmacokinetics and effects of alfaxalone after intravenous and intramuscular administration to cats

  2018cites this paper
• New and Upcoming Drugs: Intravenous Anesthetic Agents

  2017cites this paper
• A clinical evaluation of the pharmacokinetics and pharmacodynamics of intravenous alfaxalone in cyclodextrin in male and female rats following a loading dose and constant rate infusion.

  2017cites this paper
• Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABAA Receptors

  2016influential citation
• A review of the pharmacology and clinical application of alfaxalone in cats.

  2015cites this paper
• Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models

  2015cites this paper
• Learning curve of vessel cannulation in rats using cumulative sum analysis.

  2015cites this paper
• Investigation of the role of pharmacokinetics and the development of novel anti-obesity agents

  2015cites this paper
• - 1-Learning curve of cannulation of jugular and femoral vein in rats using Cumulative Summation Analysis

  2014cites this paper
• A comparison of two different ketamine and diazepam combinations with an alphaxalone and medetomidine combination for induction of anaesthesia in sheep

  2012cites this paper
• Effect of alfaxalone infusion on the electroencephalogram of dogs anaesthetized with halothane.

  2011cites this paper
• The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse.

  2011cites this paper
• Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

  2011cites this paper
• Maximizing Prediction Probability PK as an Alternative Semiparametric Approach to Estimate the Plasma Effect-Site Equilibration Rate Constant ke0

  2009cites this paper
• A novel system allowing long-term simultaneous video-electroencephalography recording, drug infusion and blood sampling in rats.

  2009cites this paper
• What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach.

  2009cites this paper
• Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling.

  2009cites this paper
• Chapter II General introduction : Disease progression and pharmacoresistance in epilepsy 2 . 1

  2008cites this paper
• Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics.

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Modulation of GABAergic inhibition by tiagabine and alphaxalone is differentially affected in the kainate model of temporal lobe epilepsy

  2008influential citation
• Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

  2007cites this paper
• Animal-to-Human Extrapolation of the Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine

  2007cites this paper
• From electric patterns to drugs: perspectives of computational neuroscience in drug design.

  2006cites this paper
• Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU.

  2006cites this paper
• Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory-Depressant Effect of Buprenorphine and Fentanyl in Rats

  2006cites this paper
• Disease System Analysis: Basic Disease Progression Models in Degenerative Disease

  2005cites this paper
• Towards a Dynamic Neuropharmacology: Integrating Network and Receptor Levels

  2005cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics

  2005cites this paper
• Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anaesthetics.

  2004cites this paper
• Mechanism-Based Pharmacodynamic Modeling for Prediction of Exposure Response

  2004cites this paper
• The interaction between vigabatrin and diazepam on the electroencephalogram during active behaviour in rats: an isobolic analysis.

  2004cites this paper
• Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalogram Effects of GABAA Receptor Modulators: In Vitro-in Vivo Correlations

  2003influential citation
• Mechanism-Based Modeling of the Pharmacodynamic Interaction of Alphaxalone and Midazolam in Rats

  2003influential citation
• Pharmacodynamic Analysis of the Interaction between Tiagabine and Midazolam with an Allosteric Model That Incorporates Signal Transduction

  2003cites this paper
• Dose-Dependent EEG Effects of Zolpidem Provide Evidence for GABAA Receptor Subtype Selectivity in Vivo

  2003cites this paper
• Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps.

  2002cites this paper
• Neuroactive Steroids Differ in Potency but Not in Intrinsic Efficacy at the GABAA Receptor in Vivo

  2002influential citation
• Multi-biomarker pharmacokinetic-pharmacodynamic relationships of central nervous systems active dopaminergic drugs

  year unknowncites this paper